Afrezza, a New Inhaled Insulin, Is Approved by the F.D.A.
Saturday, June 28, 2014 - 00:40
in Health & Medicine
The approval is a huge milestone for MannKind Corporation, but concerns linger about the drug’s potential effect on patients’ lungs.